I. Bru

Comparison of Certolizumab Pegol with Other Anticytokine Agents for Treatment of Rheumatoid Arthritis: A Multiple-treatment Bayesian Metaanalysis

O. Blin, F. Berenbaum, J. Sibilia, 2011, The Journal of Rheumatology.

Three-year clinical outcomes in patients with rheumatoid arthritis treated with certolizumab pegol: results from the observational ECLAIR study.

F. Fagnani, A. Saraux, B. Combe, 2020, Clinical and experimental rheumatology.

Medicoeconomic evaluation of hyaluronic acid for knee osteoarthritis in everyday practice: the MESSAGE study.

B. Mazières, C. Le Pen, M. Ligier, 2007, Joint, bone, spine : revue du rhumatisme.

Comparison of Certolizumab Pegol with Other Anticytokine Agents for Treatment of Rheumatoid Arthritis: A Multiple-treatment Bayesian Metaanalysis

O. Blin, F. Berenbaum, J. Sibilia, 2011, The Journal of Rheumatology.